The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases
Open accessAbstract
Limitations in therapy induced by adverse effects due to unselective drug availability and therefore the use of potentially too high doses are a common problem. One prominent example for this dilemma are inflammatory diseases. Colloidal carriers allow one to improve delivery of drugs to the site of action and appear promising to overcome this general therapeutic drawback. Specific uptake of nanoparticles by immune-related cells in inflamed barriers offers selective drug targeting to the inflamed tissue. Here we focus on nanocarrier-based drug delivery strategies for the treatment of common inflammatory disorders like rheumatoid arthritis, multiple sclerosis, uveitis or inflammatory bowel disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
The Promise of Minocycline in Neurology
Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518
Vellinga, M. M., Oude Engberink, R. D., Seewann, A., Pouwels, P. J. W., Wattjes, M. P., van der Pol, S. M. A., Pering, C., Polman, C. H., de Vries, H. E., Geurts, J. J. G., et al. (2008) · Brain · doi:10.1093/brain/awn009 · Cited by 183
Pinto-Alphandary, H., Balland, O., Laurent, M., Andremont, A., Puisieux, F., & Couvreur, P. (1994) · Pharmaceutical Research · doi:10.1023/a:1018985308984 · Cited by 53
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Liposomes in tissue engineering and regenerative medicine
Monteiro, N., Martins, A., Reis, R. L., & Neves, N. M. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0459 · Cited by 427
Leoni, G., Neumann, P.-A., Kamaly, N., Quiros, M., Nishio, H., Jones, H. R., Sumagin, R., Hilgarth, R. S., Alam, A., Fredman, G., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76693 · Cited by 354
Maisel, K., Ensign, L., Reddy, M., Cone, R., & Hanes, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.026 · Cited by 319
Organelle targeting: third level of drug targeting
Padh, H., & Sakhrani, N. (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s45614 · Cited by 269
Metadata
- Authors
- Ulbrich, W., & Lamprecht, A.
- Venue
- Journal of The Royal Society Interface
- Publisher
- The Royal Society
- Published
- 2009-11-25
- Volume
- 7
- Issue
- suppl_1
- Pages
- S55-66
- ISSN
- 1742-5662 (ISSN-L)
- 1742-5689
- OpenAlex
- W2121469147
- Cited by
- 197
- References
- 7
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. https://app.cochat.ai/papers/10.1098/rsif.2009.0285.focus
- The paper
- Ulbrich, W., & Lamprecht, A. (2010). Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. Journal of The Royal Society Interface. https://doi.org/10.1098/rsif.2009.0285.focus
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.